Literature DB >> 1586174

Phosphatidylcholine composition of endotracheal tube aspirates of neonates and subsequent respiratory disease.

M R Ashton1, A D Postle, M A Hall, S L Smith, F J Kelly, I C Normand.   

Abstract

The phosphatidylcholine (PC) content of the initial endotracheal tube aspirate was measured in 105 infants intubated for resuscitation or for ventilation for respiratory distress syndrome, using high performance liquid chromatography and postcolumn fluorescence derivitization with diphenyl-1,3,5-hexatriene. Sixty eight had measurable PC. Of the infants who developed respiratory distress syndrome, with or without subsequent chronic lung disease, neither the percentage of dipalmitoylphosphatidylcholine (DPPC) nor the ratio of DPPC to palmitoyloleoylphosphatidylcholine (POPC), showed any correlation with gestational age. However, both parameters were significantly lower overall in this group than in the group of infants who did not develop respiratory distress syndrome. Infants with a ratio of DPPC:POPC less than 3.0 developed respiratory distress syndrome irrespective of gestational age, but there was considerable overlap between groups for values greater than this. The infants with respiratory distress syndrome who went on to develop chronic lung disease had the same initial PC profile as those with respiratory distress syndrome who did not develop chronic lung disease, but differed as a group by being lighter and more premature. The development of chronic lung disease was not associated with a particular initial PC composition. Other factors related to increasing prematurity must therefore be involved in rendering infants vulnerable to developing chronic lung disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1586174      PMCID: PMC1590480          DOI: 10.1136/adc.67.4_spec_no.378

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  11 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Antioxidant activity in fetal and neonatal lung.

Authors:  M McElroy; T Postle; F Kelly
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

3.  Developmental characteristics of pulmonary superoxide dismutase: relationship to idiopathic respiratory distress syndrome.

Authors:  A P Autor; L Frank; R J Roberts
Journal:  Pediatr Res       Date:  1976-03       Impact factor: 3.756

4.  Ontogeny of surfactant apoproteins in the rat.

Authors:  D E Schellhase; P A Emrie; J H Fisher; J M Shannon
Journal:  Pediatr Res       Date:  1989-09       Impact factor: 3.756

5.  Correlations of mechanical stability, morphology, pulmonary surfactant, and phospholipid content in the developing lamb lung.

Authors:  G W Brumley; V Chernick; W A Hodson; C Normand; A Fenner; M E Avery
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

6.  Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure.

Authors:  M Hallman; T A Merritt; M Pohjavuori; L Gluck
Journal:  Pediatr Res       Date:  1986-12       Impact factor: 3.756

7.  Developmental variation in whole human lung phosphatidylcholine molecular species: a comparison with guinea pig and rat.

Authors:  A N Hunt; F J Kelly; A D Postle
Journal:  Early Hum Dev       Date:  1991-06       Impact factor: 2.079

8.  A comparison of the specificity of phosphatidylcholine synthesis by human fetal lung maintained in either organ or organotypic culture.

Authors:  P A Caesar; S J Wilson; C S Normand; A D Postle
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

9.  Absence of phosphatidylglycerol (PG) in respiratory distress syndrome in the newborn. Study of the minor surfactant phospholipids in newborns.

Authors:  M Hallman; B H Feldman; E Kirkpatrick; L Gluck
Journal:  Pediatr Res       Date:  1977-06       Impact factor: 3.756

10.  Vitamin A status of neonates with bronchopulmonary dysplasia.

Authors:  J P Shenai; F Chytil; M T Stahlman
Journal:  Pediatr Res       Date:  1985-02       Impact factor: 3.756

View more
  4 in total

1.  Bronchoalveolar lavage fluid peptidomics suggests a possible matrix metalloproteinase-3 role in bronchopulmonary dysplasia.

Authors:  Giovanni Vento; Chiara Tirone; Paola Lulli; Ettore Capoluongo; Franco Ameglio; Simona Lozzi; Francesco Cota; Fabio Mosca; Costantino Romagnoli; Irene Messana; Massimo Castagnola; Rosanna Inzitari
Journal:  Intensive Care Med       Date:  2009-09-25       Impact factor: 17.440

2.  Surfactant phosphatidylcholine composition during dexamethasone treatment in chronic lung disease.

Authors:  M R Ashton; A D Postle; D E Smith; M A Hall
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-09       Impact factor: 5.747

3.  Surfactant lipidomics in healthy children and childhood interstitial lung disease.

Authors:  Matthias Griese; Hannah G Kirmeier; Gerhard Liebisch; Daniela Rauch; Ferdinand Stückler; Gerd Schmitz; Ralf Zarbock
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

4.  Increased surfactant protein-D levels in the airways of preterm neonates with sepsis indicated responses to infectious challenges.

Authors:  Rose-Marie A Mackay; J Paul Townsend; Jennifer Calvert; Mark Anthony; Andrew R Wilkinson; Anthony D Postle; Howard W Clark; David A Todd
Journal:  Acta Paediatr       Date:  2019-01-08       Impact factor: 2.299

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.